Douglas Lane & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $169M | Sell |
663,667
-9,036
| -1% | -$2.11M | 2.29% | 4 |
|
|
2026
Q1 | $164M | Sell |
672,703
-7,524
| -1% | -$1.75M | 2.37% | 4 |
|
|
2025
Q4 | $141M | Buy |
680,227
+12,854
| +2% | +$2.54M | 1.93% | 7 |
|
|
2025
Q3 | $124M | Buy |
667,373
+34,948
| +6% | +$5.99M | 1.72% | 8 |
|
|
2025
Q2 | $96.6M | Buy |
632,425
+14,750
| +2% | +$2.27M | 1.4% | 17 |
|
|
2025
Q1 | $102M | Buy |
617,675
+18,289
| +3% | +$2.86M | 1.51% | 14 |
|
|
2024
Q4 | $86.7M | Buy |
599,386
+6,526
| +1% | +$1.01M | 1.22% | 21 |
|
|
2024
Q3 | $96.1M | Buy |
592,860
+15,508
| +3% | +$2.47M | 1.32% | 18 |
|
|
2024
Q2 | $84.4M | Buy |
577,352
+32,098
| +6% | +$4.77M | 1.2% | 25 |
|
|
2024
Q1 | $86.3M | Buy |
545,254
+24,686
| +5% | +$3.93M | 1.22% | 24 |
|
|
2023
Q4 | $81.6M | Buy |
520,568
+40,363
| +8% | +$6.19M | 1.26% | 27 |
|
|
2023
Q3 | $74.8M | Buy |
480,205
+33,412
| +7% | +$5.51M | 1.26% | 25 |
|
|
2023
Q2 | $74M | Buy |
446,793
+34,122
| +8% | +$5.51M | 1.19% | 32 |
|
|
2023
Q1 | $64M | Buy |
412,671
+16,174
| +4% | +$2.61M | 1.06% | 42 |
|
|
2022
Q4 | $70M | Buy |
396,497
+36,277
| +10% | +$6.26M | 1.17% | 41 |
|
|
2022
Q3 | $58.8M | Buy |
360,220
+3,369
| +0.9% | +$570K | 1.09% | 37 |
|
|
2022
Q2 | $63.3M | Buy |
356,851
+7,638
| +2% | +$1.36M | 1.08% | 38 |
|
|
2022
Q1 | $61.9M | Buy |
349,213
+37,212
| +12% | +$6.33M | 0.87% | 47 |
|
|
2021
Q4 | $53.4M | Buy |
312,001
+48,438
| +18% | +$7.93M | 0.71% | 56 |
|
|
2021
Q3 | $42.6M | Buy |
263,563
+23,548
| +10% | +$4.02M | 0.61% | 69 |
|
|
2021
Q2 | $39.5M | Buy |
240,015
+21,764
| +10% | +$3.6M | 0.55% | 74 |
|
|
2021
Q1 | $35.9M | Buy |
218,251
+23,243
| +12% | +$3.76M | 0.56% | 74 |
|
|
2020
Q4 | $30.7M | Buy |
195,008
+39,822
| +26% | +$5.88M | 0.51% | 77 |
|
|
2020
Q3 | $23.1M | Buy |
155,186
+7,966
| +5% | +$1.18M | 0.46% | 74 |
|
|
2020
Q2 | $20.7M | Buy |
147,220
+22,898
| +18% | +$3.34M | 0.44% | 76 |
|
|
2020
Q1 | $16.3M | Buy |
124,322
+58,700
| +89% | +$8.33M | 0.43% | 74 |
|
|
2019
Q4 | $9.57M | Buy |
65,622
+1,117
| +2% | +$152K | 0.18% | 101 |
|
|
2019
Q3 | $8.35M | Buy |
64,505
+407
| +0.6% | +$53.6K | 0.17% | 105 |
|
|
2019
Q2 | $8.93M | Sell |
64,098
-1,581
| -2% | -$219K | 0.17% | 103 |
|
|
2019
Q1 | $9.18M | Buy |
65,679
+405
| +0.6% | +$54.2K | 0.19% | 100 |
|
|
2018
Q4 | $8.42M | Sell |
65,274
-2,921
| -4% | -$407K | 0.2% | 101 |
|
|
2018
Q3 | $9.42M | Sell |
68,195
-558
| -0.8% | -$74.2K | 0.19% | 99 |
|
|
2018
Q2 | $8.34M | Sell |
68,753
-1,853
| -3% | -$231K | 0.18% | 99 |
|
|
2018
Q1 | $9.05M | Sell |
70,606
-2,709
| -4% | -$366K | 0.2% | 98 |
|
|
2017
Q4 | $10.2M | Sell |
73,315
-7,315
| -9% | -$1.02M | 0.22% | 97 |
|
|
2017
Q3 | $10.5M | Buy |
80,630
+1,858
| +2% | +$246K | 0.24% | 93 |
|
|
2017
Q2 | $10.4M | Sell |
78,772
-3,192
| -4% | -$407K | 0.25% | 94 |
|
|
2017
Q1 | $10.2M | Buy |
81,964
+3,680
| +5% | +$440K | 0.25% | 92 |
|
|
2016
Q4 | $9.02M | Sell |
78,284
-1,514
| -2% | -$175K | 0.23% | 101 |
|
|
2016
Q3 | $9.43M | Sell |
79,798
-4,327
| -5% | -$525K | 0.25% | 98 |
|
|
2016
Q2 | $10.2M | Sell |
84,125
-1,545
| -2% | -$176K | 0.29% | 99 |
|
|
2016
Q1 | $9.27M | Buy |
+85,670
| New | +$8.87M | 0.25% | 104 |
|
Other funds holding JNJ
Douglas Lane & Associates's JNJ Position: Q2 2026 in Review
Douglas Lane & Associates reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, selling an estimated $2.11M and leaving 663,667 shares worth $169M. The position accounts for 2.29% of the portfolio, ranked #4.
Douglas Lane & Associates first reported a position in JNJ in Q1 2016 and has held it in 42 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Douglas Lane & Associates held 663,667 shares of Johnson & Johnson worth $169M as of Q2 2026.
- Douglas Lane & Associates sold 9,036 Johnson & Johnson shares in Q2 2026, an estimated $2.11M.
- Johnson & Johnson made up 2.29% of Douglas Lane & Associates's portfolio in Q2 2026, its #4 holding.
- Douglas Lane & Associates first reported a position in Johnson & Johnson in Q1 2016 and has held it in 42 quarters since.
- 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.